← Snapshot 21

Orange Book snapshot 21: Products

Products page 296 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
14752A090030002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA100MG/20ML (5MG/ML)AP["AP"]2017-01-31Jan 31, 2017NoNoNoRXFRESENIUS KABI USA LLC172e616afd6a4e9de1a1c5b0b4e171da764cd63a921d0091a9e61b56bacaae04
14753A090030003OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA200MG/40ML (5MG/ML)[]2017-01-31Jan 31, 2017NoNoNoDISCNFRESENIUS KABI USA LLCb34e74871a666ed03f5e84e24bd9b570b888baf706c6529871e41124c4770a61
14754A207325001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINGLAND PHARMA LTD50MG/10ML (5MG/ML)AP["AP"]2017-02-10Feb 10, 2017NoNoNoRXGLAND PHARMA LTDe9fefbe5f4c6d9894a132e02ed1d410c61a678e38baec67dafe55c1cf965d69b
14755A207385001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINGLAND PHARMA LTD50MG/VIALAP["AP"]2017-05-23May 23, 2017NoNoNoRXGLAND PHARMA LTD55d131fb19af5172fc7a7042a615b234db28f64d085b36a6e22d1e3939ad36f9
14756A207325002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINGLAND PHARMA LTD100MG/20ML (5MG/ML)AP["AP"]2017-02-10Feb 10, 2017NoNoNoRXGLAND PHARMA LTD0bf1f35126e627d90ba20db9b0e01c3a460ebd7d92ee512337ef7c21fb51794c
14757A207385002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINGLAND PHARMA LTD100MG/VIALAP["AP"]2017-05-23May 23, 2017NoNoNoRXGLAND PHARMA LTDdc852a7566e736d9f93d9911d410131606ed31d58a78eb001629ef4e543313cb
14758A207325003OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINGLAND PHARMA LTD200MG/40ML (5MG/ML)[]2017-10-18Oct 18, 2017NoNoNoDISCNGLAND PHARMA LTD59b22af1f33982b1bac65195e5914524a294f09bb81d903ed274f2334b29d086
14759A078815001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINHOSPIRA INC50MG/VIAL[]2009-09-30Sep 30, 2009NoNoNoDISCNHOSPIRA INCbd189425415d42357e4e82164579d18b22e8d1bd0240f56008e6db97ae8b80b7
14760A078815002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINHOSPIRA INC100MG/VIAL[]2009-09-30Sep 30, 2009NoNoNoDISCNHOSPIRA INC85b3417677abe6b9130ee140fc41315c6119f9ed53a7ef27826186aa508f533c
14761A078813001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINHOSPIRA WORLDWIDE50MG/10ML (5MG/ML)AP["AP"]2009-08-07Aug 7, 2009NoNoNoRXHOSPIRA WORLDWIDE PTYd3fbc5f719ca796a41fd5482af4fd89bda91b64b752ac5a9934a4d454d716f10
14762A078813002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINHOSPIRA WORLDWIDE100MG/20ML (5MG/ML)AP["AP"]2009-08-07Aug 7, 2009NoNoNoRXHOSPIRA WORLDWIDE PTY0c2250870b47debaa2787908f64b66bacd6c4a282d2fddc96f162a4ec93002ed
14763A207562001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATININGENUS PHARMS LLC50MG/10ML (5MG/ML)AP["AP"]2018-10-16Oct 16, 2018NoNoNoRXINGENUS PHARMACEUTICALS LLC6159299cb4a520102e6256d9c15f3887f9e9eca602a6d561e09ea2b2bbb0c7ad
14764A207562002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATININGENUS PHARMS LLC100MG/20ML (5MG/ML)AP["AP"]2018-10-16Oct 16, 2018NoNoNoRXINGENUS PHARMACEUTICALS LLCef83b8a2cab7eb99d4caa3bb4eee575a15ed0ea6540751d60396b9c713be34cd
14765A203869001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINJIANGSU HENGRUI MED50MG/10ML (5MG/ML)AP["AP"]2014-06-18Jun 18, 2014NoNoNoRXJIANGSU HENGRUI MEDICINE CO LTD63ff0deff03ff9ecc6fd37e3ea1d6a15f8220b4c1ac659d9c97c1b91b875a414
14766A203869002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINJIANGSU HENGRUI MED100MG/20ML (5MG/ML)AP["AP"]2014-06-18Jun 18, 2014NoNoNoRXJIANGSU HENGRUI MEDICINE CO LTDd01f334649e5e6226a886fa7da091926698782c1430e53cb085b9dd72614cb85
14767A091358001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINMYLAN LABS LTD50MG/10ML (5MG/ML)AP["AP"]2012-08-07Aug 7, 2012NoNoNoRXMYLAN LABORATORIES LTD43a5187fff6dfea72f34fb0afd87441a091c13cad5ccf3eb5de95bd85aca23f1
14768A200979001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINMYLAN LABS LTD50MG/VIAL[]2012-08-08Aug 8, 2012NoNoNoDISCNMYLAN LABORATORIES LTDb1f94289d6329cbc874cf0117a57da26b006e186c5c477f572ca30b71737beae
14769A091358002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINMYLAN LABS LTD100MG/20ML (5MG/ML)AP["AP"]2012-08-07Aug 7, 2012NoNoNoRXMYLAN LABORATORIES LTDce8c28719d033bb5ad98fb98ff92986ca5320eb1f7726e1c3a2094ce05242f73
14770A200979002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINMYLAN LABS LTD100MG/VIAL[]2012-08-08Aug 8, 2012NoNoNoDISCNMYLAN LABORATORIES LTD29368878346441cfe317168ea7ee0650a3438b0c83ac1dbe11246d0ee1c2d9f5
14771A091358003OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINMYLAN LABS LTD200MG/40ML (5MG/ML)[]2017-11-14Nov 14, 2017NoNoNoDISCNMYLAN LABORATORIES LTD158d11f26706c5b7e596020f3adde75809f1b91f7484dbdcd136edc5d75561de
14772A204368001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINQILU50MG/10ML (5MG/ML)AP["AP"]2016-06-07Jun 7, 2016NoNoNoRXQILU PHARMACEUTICAL CO LTD9a965ac423807782c82a81321134313cdfa29362d20554b264788752b7a9924c
14773A204616001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINQILU50MG/VIALAP["AP"]2016-05-11May 11, 2016NoNoNoRXQILU PHARMACEUTICAL CO LTDad619cac995ac12823605c6a5a6273564e6d51f95429a08175f86b408fdd44f4
14774A204368002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINQILU100MG/20ML (5MG/ML)AP["AP"]2016-06-07Jun 7, 2016NoNoNoRXQILU PHARMACEUTICAL CO LTDf377de7caee933d4ef4a16955b07bf9222380ef40b022a35dff4cb2806b95be5
14775A204616002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINQILU100MG/VIALAP["AP"]2016-05-11May 11, 2016NoNoNoRXQILU PHARMACEUTICAL CO LTD81bf2a2415c99bf98844c43bc67351211b16269359cb32e5e9a3edfef4bde395
14776A204368003OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINQILU200MG/40ML (5MG/ML)[]2016-06-07Jun 7, 2016NoNoYesRXQILU PHARMACEUTICAL CO LTDc1bbeb96d1cc9665ca9e7829eb2f7b8cad76242915451d6edf1d6ec99b2c17f1
14777A078817001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSANDOZ50MG/10ML (5MG/ML)AP["AP"]2011-01-24Jan 24, 2011NoNoNoRXSANDOZ INC46869abe9d385d633f8e4ddccc79b4c0383b88f7da1d3482eabf8c27eea094f9
14778A090849001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSANDOZ50MG/VIAL[]2011-04-28Apr 28, 2011NoNoNoDISCNSANDOZ INCb9fe4a412d8b3fa0c7a437f8b55512d29a1e342dc2c4dc1d69300b0124c5e3e3
14779A078817002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSANDOZ100MG/20ML (5MG/ML)AP["AP"]2011-01-24Jan 24, 2011NoNoNoRXSANDOZ INCc33dfb8d3803bb68cc2f187e7ff24e16f06f09528838c2369db733f7233d5776
14780A090849002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSANDOZ100MG/VIAL[]2011-04-28Apr 28, 2011NoNoNoDISCNSANDOZ INCa75b80ec4fd0c80c8366cdc304344c1bfea05990ba6bdd576fe9a451bdcd8886
14781A078812001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSANDOZ INC50MG/10ML (5MG/ML)[]2009-08-07Aug 7, 2009NoNoNoDISCNSANDOZ INC3cd58399e087ae7b4271891564a1a501db8454338d4ce94a886812fdc58bf567
14782A078812002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSANDOZ INC100MG/20ML (5MG/ML)[]2009-08-07Aug 7, 2009NoNoNoDISCNSANDOZ INCa07c98b9537429cbb033c6da4f02fddc70b7abfc772673ab054910cf93626dde
14783A078818001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSUN PHARM50MG/VIAL[]2009-08-07Aug 7, 2009NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDa2d4313afbae85284f53ea317a7bc427893fe1dddac76264d41c670864503bf5
14784A202922001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSUN PHARM50MG/10ML (5MG/ML)[]2014-04-08Apr 8, 2014NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTD1cf158fcdf0fac26aafa722c687dcda7bad7fbeba795b7e12395ebe96c961a82
14785A078818002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSUN PHARM100MG/VIAL[]2009-08-07Aug 7, 2009NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTD5eae972341c40cff7cec9bc526985254482dca67ec46fd3150511c611fbce8e8
14786A202922002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSUN PHARM100MG/20ML (5MG/ML)[]2014-04-08Apr 8, 2014NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDf04e5acbe9915b0f0941736200d5f6191e7ae57ed0c55a6935ff9721ec0e7bef
14787A202922003OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINSUN PHARM200MG/40ML (5MG/ML)[]2019-02-15Feb 15, 2019NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDf51081011057f489c176060991f5a0c4c92dae92b36b1c79440b592fc0016bc6
14788N022160001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINTEVA PHARMS50MG/10ML (5MG/ML)AP["AP"]2009-08-07Aug 7, 2009NoYesYesRXTEVA PHARMACEUTICALS USAaa8b094c2299415f9621c95dcac9a3e56c73c41790f239c700c7f692d31e974b
14789N022160002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINTEVA PHARMS100MG/20ML (5MG/ML)AP["AP"]2009-08-07Aug 7, 2009NoYesYesRXTEVA PHARMACEUTICALS USA69d892a95c38be6e802d8197511097605ba7072121e45feca143873c0aeefce0
14790A204615001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEACCORD HLTHCAREEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2021-03-15Mar 15, 2021NoNoNoRXACCORD HEALTHCARE INC94c0111cc589364a546a74801318d1e5c69ba8d120d9369cd475c9c72153072b
14791A204702001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEAUROBINDO PHARMA LTDEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-11-06Nov 6, 2018NoNoNoRXAUROBINDO PHARMA LTDeef02458a86d8b729bd02693c1e9178fc1a249c31eed3390e8ecaad43836a1a0
14792A206396001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDECIPLAEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXCIPLA LTD72207269ca7e5e1a01eb92c3dfe4a3d369408291be06120691fe6374d35e89bd
14793A201533001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEDR REDDYS LABS LTDEQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)[]2016-04-21Apr 21, 2016NoNoNoDISCNDR REDDYS LABORATORIES LTD7806e321ba690dbec9aad914b03a41a455226085a8f85979fd5cf68405a22b0f
14794A201533002PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEDR REDDYS LABS LTDEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2016-04-21Apr 21, 2016NoNoNoRXDR REDDYS LABORATORIES LTD2d0df9a3d242b8d275c121574ff05c51c8d2752018c9a6fa3225152bb69d799c
14795A206801001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEFRESENIUS KABI USAEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXFRESENIUS KABI USA LLCe20cb8a623f7dbd94189509239b55f5dcc987f9d57abad7b54ef439a376c604b
14796A206802001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEFRESENIUS KABI USAEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXFRESENIUS KABI USA LLC1ec37051c0809d8161c1f5412319645d8b2830d3b1e3d03664736e8e3f11860c
14797A207005001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEHOSPIRA INCEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXHOSPIRA INC634a8108e5557046c8993ec2ecab6a856ce1a7eb64ba0e346f938f9fe85642ec
14798A207005002PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEHOSPIRA INCEQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXHOSPIRA INC1eaf0cb27d4598a5fb5a96a23c82be50e99e3a1d85ec14d8fd8ede144c3fa227
14799A208789001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEINGENUS PHARMS LLCEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2020-05-22May 22, 2020NoNoNoRXINGENUS PHARMACEUTICALS LLCe3d805564f4e613b2adb4543afd3ff4915f2f8411dd49d096d46ab183a55a006
14800A206416001PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEMYLAN INSTITUTIONALEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXMYLAN INSTITUTIONAL LLCe11ee0cad3c0b44ce26199811dccd9a62200e6c9ab322816a097b48750c8b26e
14801A205648002PALONOSETRON HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSPALONOSETRON HYDROCHLORIDEQILUEQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)AP["AP"]2018-09-19Sep 19, 2018NoNoNoRXQILU PHARMACEUTICAL CO LTD731eba032e1668a5089443714bed64506eb59d8666be21716b896c9a5d0a6614